Prophylactic STI Treatment for Male with Severe Penicillin Allergy After Chlamydia Exposure

Chlamydia Treatment

The Centers for Disease Control and Prevention recommends azithromycin 1 g orally as a single dose for chlamydia coverage, with cure rates of 97% 1, 2
Doxycycline 100 mg orally twice daily for 7 days achieves 98% cure rates for chlamydia treatment 1, 2
Azithromycin has advantages, including single-dose directly observed therapy, no cross-reactivity with penicillin, and effectiveness against both urogenital and rectal chlamydia infections 1, 2

For patients with severe penicillin allergy, spectinomycin 2 g intramuscularly as a single dose is recommended for gonorrhea treatment, with a cure rate of 98.2% 3
Ciprofloxacin 500 mg orally as a single dose can be used as an alternative for gonorrhea prophylaxis if local resistance patterns permit 3
The Centers for Disease Control and Prevention notes that cephalosporins have potential cross-reactivity with penicillin in patients with severe IgE-mediated reactions, making them contraindicated for gonorrhea treatment in these cases 3, 4

For confirmed or suspected chlamydia exposure, azithromycin 1 g orally as a single dose is recommended, with directly observed first dose 1, 2, 5
If gonorrhea prophylaxis is also needed, spectinomycin 2 g intramuscularly or ciprofloxacin 500 mg orally as a single dose can be used, depending on local resistance patterns and availability 3

Severe IgE-mediated reactions to penicillin contraindicate cephalosporins, and approximately 90% of patients reporting penicillin allergy are no longer allergic 4, 6
Spectinomycin availability is limited, and fluoroquinolones may be the only option despite resistance concerns if cephalosporins are contraindicated and spectinomycin is unavailable 3
Patients should be instructed to abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen, and all sexual partners from previous 60 days should be evaluated and treated 1, 2, 5

The Centers for Disease Control and Prevention recommends that patients with documented anaphylaxis to penicillin should avoid cephalosporins due to potential cross-reactivity risk 7

Spectinomycin 2 g intramuscularly as a single dose is the recommended alternative for uncomplicated urogenital and anorectal gonorrhea, with 98.2% cure rates, as stated by the CDC 8
The CDC advises that fluoroquinolones should NOT be used in men who have sex with men (MSM), patients with recent foreign travel, or infections acquired in areas with known quinolone-resistant N. gonorrhoeae (QRNG) 9

The CDC recommends that all sexual partners from the preceding 60 days must be evaluated and treated with the same dual therapy regimen for both gonorrhea and chlamydia 9
Test of cure is NOT routinely required for patients treated with recommended regimens unless symptoms persist, as per the CDC guidelines 9

The CDC advises to never use azithromycin 2 g alone for gonorrhea—it causes significant gastrointestinal distress and has insufficient efficacy (93%) 9
The CDC recommends to never use macrolides (erythromycin) for gonorrhea—N. gonorrhoeae in the United States is not adequately susceptible 9
The CDC warns to never assume spectinomycin will work for pharyngeal infections—efficacy is only 52% at this site, and fluoroquinolones are the only viable option if susceptibility permits 9